How often ketoacidosis occurs in type 1 diabetes with a glucose and ketone monitor
Tracks diabetic ketoacidosis in children and adults with type 1 diabetes using monitors.
Plain-language title generated from the registry record
Registry title: Evaluating the Occurrence of DKA in People With Type I Diabetes
Key facts
- Where
- Auckland, Christchurch, Dunedin, Hamilton, Palmerston North, Rosedale, and Wellington, New ZealandSee the 7 sites
Where in New Zealand
- Optimal Clinical TrialsAuckland, New ZealandNo longer taking part
- New Zealand Clinical ResearchChristchurch, New ZealandNo longer taking part
- Health New Zealand-SouthernDunedin, New ZealandNo longer taking part
- Aotearoa Diabetes CollectiveHamilton, New ZealandNo longer taking part
- Te Pae Hauora o Ruahine o Tararua /MidCentral Health New ZealandPalmerston North, New ZealandNo longer taking part
- Optimal Clinical Trials (North)Rosedale, New ZealandNo longer taking part
- New Zealand Clinical ResearchWellington, New ZealandNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Abbott Diabetes Care
- Trial code
- NCT07739342
- Record updated
- 31 July 2026
- Original description
This study will evaluate the occurrences of Diabetes-related Ketoacidosis (DKA) in adult and pediatric individuals living with Type I diabetes while managing diabetes with Abbott's Continuous Monitoring Systems.Read full original descriptionShow less
Evaluating the Occurrence of DKA in People With Type 1 Diabetes
This study will evaluate the occurrences of Diabetes-related Ketoacidosis (DKA) in adult and pediatric individuals living with Type I diabetes while managing diabetes with Abbott's Continuous Monitoring Systems.
Inclusion: Aged at least 2 years old at the time of study enrollment; Diagnosis of type 1 diabetes with at least 12 months of diabetes medical history; In the investigator's opinion, the participant is willing to wear the sensor, follow study specific instructions, and perform all study tasks; Willing and able to provide written signed and dated informed consent (adults) or participant's parent/legal guardian must be willing and able to provide written signed and dated informed consent along with assent form completed by the participant for those mature enough to make their own decisions per investigator assessment (those less than 16 years of age).
Exclusion: In the investigator's opinion, the participant has concomitant medical condition(s) which could interfere with the study or present a risk to the safety or welfare of the participant or study staff; In the investigator's opinion, the participant has a known (or suspected) allergy to medical grade adhesives at enrollment that would interfere with participant completing study required activities; Participant is currently in another clinical study which may affect glucose or ketone management (or does so during the study); Participant is unsuitable for participation due to any other cause as determined by the investigator; Participant has implanted medical devices such as pacemakers or requires dialysis or is critically ill.